Research map: BCMA ‐ CD19 CAR T Cells in Systemic Lupus Erythematosus: Humoral Reset or Antigen‐Specific Tolerance?

Back to the article

Papers in this map

  1. Anti-CD19 CAR T cell therapy for refractory systemic lupus erythematosus · Andréas Mackensen · 2022 · 1101 citations · Cited by this paper
  2. The Role of IgM Anti‐acetylated Protein Antibodies and B Cells in the Origin of Antimodified Protein Autoimmunity in Rheumatoid Arthritis · 2026 · Related
  3. CD19 CAR T-Cell Therapy in Autoimmune Disease — A Case Series with Follow-up · Fabian Müller · 2024 · 1085 citations · Cited by this paper
  4. Reply · 2026 · Related
  5. Diversity, cellular origin and autoreactivity of antibody-secreting cell population expansions in acute systemic lupus erythematosus · Christopher M. Tipton · 2015 · 610 citations · Cited by this paper
  6. Integrated Clinical and Proteomic Profiling of CD19 Chimeric Antigen Receptor T Cell Therapy in Progressive Systemic Sclerosis · 2026 · Related
  7. BCMA-CD19 compound CAR T cells for systemic lupus erythematosus: a phase 1 open-label clinical trial · Weijia Wang · 2024 · 227 citations · Cited by this paper
  8. Distinct Molecular Pathways Supporting Sjögren Disease Clusters and Disease Progression · 2026 · Related
  9. Epstein-Barr virus reprograms autoreactive B cells as antigen-presenting cells in systemic lupus erythematosus · Shady Younis · 2025 · 85 citations · Cited by this paper
  10. Dermatomyositis in skin of color population: expanding clinical recognition · 2026 · Related
  11. Co-infusion of CD19-targeting and BCMA-targeting CAR-T cells for treatment-refractory systemic lupus erythematosus: a phase 1 trial · Jingjing Feng · 2025 · 69 citations · Cited by this paper
  12. Age‐associated B cells contribute to inflammation via antibody‐independent mechanisms in Takayasu's arteritis · 2026 · Related
  13. BCMA/CD19 CAR T cell therapy for refractory myasthenia gravis: Proteomic signatures and single-cell transcriptomics of disease flares · Xiaoyu Huang · 2026 · 14 citations · Cited by this paper
  14. Deucravacitinib in Active Psoriatic Arthritis: Efficacy and Safety up to 52 Weeks From the Randomized, Double‐Blind, Phase 3 POETYK PsA‐2 Trial · 2026 · Related
  15. Dual‐Targeting BCMA – CD19 CAR ‐T Cell Therapy in Systemic Lupus Erythematosus: Single‐Cell and Immune Repertoire Analysis Reveals Mechanisms of Immune Reconstitution · Zhenghao He · 2026 · 7 citations · Cited by this paper
  16. Outcomes in progressive pulmonary fibrosis in systemic autoimmune rheumatic diseases: real‐world data from the ILD ‐ PRO Registry · 2026 · Related
  17. B-Cell Maturation Antigen-CD19 Dual-Targeted Chimeric Antigen Receptor-T–Cell Therapy for Relapsed or Refractory AL Amyloidosis · Xianghua Huang · 2026 · 1 citation · Cited by this paper
  18. Cytokine‐induced NRP2 expression in rheumatoid arthritis fibroblast‐like synoviocytes: comment on the article by Jin et al · 2026 · Related
  19. Human Fibroblast–Myeloid Cell Tissue Atlas Across the Lungs, Synovium, Skin, and Heart · 2026 · Related

Source: OpenAlex (CC0)